Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Pimecrolimus vs Methylprednisolone in Infants with Atopic Dermatitis
NCT04900948Phase 4Completed
- Start
- Dec 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms). Primary endpoints: Change from baseline response based on the specific IgE level and Change from baseline response based on the class of sensitization. Started Dec 2017; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04900948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04900948.